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Cryptococcus neoformans Phosphoinositide-Dependent Kinase 1
(PDK1) Ortholog Is Required for Stress Tolerance and Survival in
Murine Phagocytes
Yeissa Chabrier-Roselló,a Kimberly J. Gerik,c Kristy Koselny,a Louis DiDone,a Jennifer K. Lodge,c Damian J. Krysana,b
Departments of Pediatricsa and Microbiology/Immunology,b University of Rochester, Rochester, New York, USA; Department of Molecular Microbiology, Washington
University School of Medicine, St. Louis, Missouri, USAc
Cryptococcus neoformans PKH2-01 and PKH2-02 are orthologous to mammalian PDK1 kinase genes. Although orthologs of
these kinases have been extensively studied in S. cerevisiae, little is known about their function in pathogenic fungi. In this
study, we show that PKH2-02 but not PKH2-01 is required for C. neoformans to tolerate cell wall, oxidative, nitrosative, and an-
tifungal drug stress. Deletion of PKH2-02 leads to decreased basal levels of Pkc1 activity and, consequently, reduced activation of
the cell wall integrity mitogen-activated protein kinase (MAPK) pathway in response to cell wall, oxidative, and nitrosative
stress. PKH2-02 function also is required for tolerance of fluconazole and amphotericin B, two important drugs for the treat-
ment of cryptococcosis. Furthermore, OSU-03012, an inhibitor of human PDK1, is synergistic and fungicidal in combination
with fluconazole. Using a Galleria mellonellamodel of low-temperature cryptococcosis, we found that PKH2-02 is also required
for virulence in a temperature-independent manner. Consistent with the hypersensitivity of the pkh2-02mutant to oxidative
and nitrosative stress, this mutant shows decreased survival in murine phagocytes compared to that of wild-type (WT) cells. In
addition, we show that deletion of PKH2-02 affects the interaction between C. neoformans and phagocytes by decreasing its abil-
ity to suppress production of tumor necrosis factor alpha (TNF-) and reactive oxygen species. Taken together, our studies dem-
onstrate that Pkh2-02-mediated signaling in C. neoformans is crucial for stress tolerance, host-pathogen interactions, and both
temperature-dependent and -independent virulence.
Cryptococcus species are basidiomycetous fungi that are an im-portant contributor to human disease worldwide (1). The vast
majority of cryptococcal disease is caused by C. neoformans var.
grubii, also known as serotype A, which affects patients with com-
promised immune function and manifests as meningoencephali-
tis (CEM). Recent epidemiological estimates indicate that approx-
imately one million new cases of CEM occur each year and that
600,000 people die from the disease annually (2). HIV infection is
the most common risk factor for CEM, and accordingly, CEM is
one of the most common AIDS-defining opportunistic infections
(3). More recently, an ongoing outbreak of C. neoformans var.
gattii infections in the Pacific Northwest region of North America
has emerged among apparently immunocompetent patients (4).
Finally, cryptococcal disease continues to affect people who are
undergoing therapy with immunomodulatory medications de-
signed to treat other conditions (5). Thus,Cryptococcus species are
an important and dynamic cause of human infectious disease.
Current antifungal therapy for cryptococcosis is based on two
regimens: amphotericin preparations combined with 5-flucyto-
sine in resource-rich regions and fluconazole in resource-limited
regions (6). Both regimens have drawbacks; amphotericin B-flu-
cytosine is expensive, toxic, and logistically impractical in regions
with the highest burden of disease, while fluconazole, although
safe and inexpensive, is less effective due to its fungistatic mode of
action (6, 7). Themost recent additions to the antifungal pharma-
copeia, echinocandin 1,3--glucan synthase inhibitors, do not
have clinically useful activity towardCryptococcus spp., and there-
fore, no new classes of anticryptococcal agents have been brought
to the clinic in over 20 years (8). Thus, the identification and
development of new agents with activity towardCryptococcus con-
stitute an area of active research.
A deeper understanding of the biology and pathogenesis of
Cryptococcus will be required if new approaches to treatment are
to be developed. A high-yield area of research in this regard would
seem to be the study of signal transduction pathways, since these
networks are central to the regulation of a wide variety of biolog-
ical processes in all eukaryotes. Accordingly, a number of groups
have investigated the role of signal transduction pathways in the
biology and pathogenesis of Cryptococcus (9–11). Among the
pathways that have been studied are the cell wall integrity mito-
gen-activated kinase pathway (12), the calmodulin-calcineurin
pathway (13), the protein kinase A pathway (14), and the hyper-
osmolar-glycerol (HOG) pathway (15). Many of these pathways
are conserved across fungal species in general and, as such, have
been extensively studied in the model yeast Saccharomyces cerevi-
siae. However, it is important to note that important differences
between the model yeast and pathogenic yeast with respect to
pathway function and/or pathway structure have been identified
(16).
Recently, the Krysan laboratory reported that molecules tar-
geting human phosphoinositide-dependent kinase 1 (hPDK1)
have excellent in vitro activity toward bothCandida spp. andCryp-
tococcus spp. and appear to target the fungal orthologs of PDK1
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(17). In S. cerevisiae (18), three kinases have homology to hPDK1,
and these genes have been named PKH1, -2, and -3. PKH1 and
PKH2 encode a redundant pair of kinases that carry out essential
functions in S. cerevisiae, as evidenced by the fact that deletion of
one has no phenotype while deletion of both genes is lethal (19).
PDK1 and Pkh kinases are members of the AGC superfamily of
protein kinases (18). In addition to being the subject of intensive
study in mammalian and human cells due to their role in human
cancers (20), PDK1/Pkh kinases have been well characterized in S.
cerevisiae. These studies have shown that the Pkhs regulate a wide
variety of cellular functions in S. cerevisiae, including cell wall
integrity (21), sphingolipid biosynthesis (22, 23), endocytosis
(24), eisosome formation (25, 26), flippase activity (22), and RNA
metabolism (25). In S. cerevisiae, six key Pkh substrates have been
identified, i.e., the AGC kinases protein kinase A (PKA), Pkc1,
Ypk1/2, and Sch9 as well as a component of the eisosome, Pil1
(26–29).
Prior to the initiation of this work, very little was known about
the function of PDK1 orthologs in pathogenic fungi. PDK1/Pkh
orthologs in both Candida albicans and Cryptococcus neoformans
had been identified and deleted as part of large-scale genetic
screening projects (30, 31). In C. neoformans, two genes with ho-
mology to hPDK1have been identified and annotated asPKHs. As
part of their large-scale gene deletion project (31), Liu et al. gen-
erated CNAG_02820 (PKH2-01) and CNAG_02915 (PKH2-02)
deletionmutants.While the pkh2-01mutant had no phenotypes
with respect to high-temperature growth, melanin formation, or
capsule generation, the pkh2-02mutant was temperature sensi-
tive and, accordingly, showed decreased virulence in a mouse
model of pulmonary cryptococcosis (31).
As our work was in progress, Lee et al. reported a series of
experiments investigating the role of PKHs in fluconazole suscep-
tibility and renamed PKH2-02 as PDK1; they also suggested that
because the PKH2-01 product does not have a clearly definable
catalytic domain, it may not be a true PDK1/Pkh kinase (32).
Deletion of C. neoformans PKH2-02 (CnPKH2-02) led to de-
creased fluconazole tolerance as well as hypersensitivity to high
salt, rapamycin, aureobasidinA,myriocin, and phytosphingosine.
In addition, Lee et al. found that activation of the cell wall integrity
(CWI) mitogen-activated protein kinase (MAPK) cascade by flu-
conazole was dependent on PKH2-02 and that pkh2-02mutants
have altered sphingolipid profiles. They also provided data that
suggest that PKH2-02-dependent fluconazole tolerance is medi-
ated by phosphorylation of Ypk1 (32).
Here we report our characterization of the role of PKH2-02 in
the ability ofC. neoformans to tolerate a variety of stresses, includ-
ing cell wall, oxidative, and nitrosative stress. Our data indicate
that activation of the CWI pathway in response to cell wall, oxi-
dative, and nitrosative stress is modulated by PKH2-02. We have
also found that the role of PKH2-02 in virulence is not limited to
its function in supporting high-temperature growth. Specifically,
C. neoformans is known to modulate phagocyte activation and
suppress tumor necrosis factor alpha (TNF-) production in a
process that we have found is dependent on PKH2-02. Further-
more, we show that C. neoformans, like other pathogenic fungi
(33–35), suppresses production of reactive oxygen species (ROS)
by mouse macrophage-like J774 cells and that this process is also
PKH2-02dependent. Taken togetherwith our previouswork (17),
these data indicate that CnPKH2-02-mediated signaling is crucial
to C. neoformans stress tolerance and host-pathogen interactions
and, consequently, further support the notion that PKHs repre-
sent a highly attractive antifungal drug target.
MATERIALS AND METHODS
Strains, growth conditions, andmaterials.Cryptococcus neoformans var.
grubii CM018 and a derived isolate obtained from the deletion collection
assembled by Liu et al. (31) were used as reference strains and are noted as
wild type (WT) in this paper. The mpk1, lac1, and cap59 deletion
mutants were also obtained from the deletion collection (31), and the
expected phenotypes reported for those strains were confirmed prior to
use in assays. Yeast strains were grown in yeast extract-peptone-dextrose
(YPD) or synthetic dropout medium prepared according to standard rec-
ipes (36). All incubations were performed at 30°C unless noted otherwise.
DH5 Escherichia coli cells (Invitrogen, Carlsbad, CA) were used for rou-
tine plasmid manipulations. Except for OSU-03012 (Selleck Chemicals,
Houston, TX), all chemicals were obtained from Sigma (St. Louis, MO)
and used as received. Oligonucleotides were synthesized by IDT (Cor-
alville, IA).
Construction and complementation of PKH2-02 mutants. The
pkh2-02mutant from the deletion collection generated by Liu et al. (31)
was utilized, and it genotype was confirmed as described below. PKH2-02
was also deleted in KN99 using standard single-gene deletion methods
and biolistic transformation. A linear cassette containing flanking se-
quences complementary to the 5= and 3= untranslated regions of PKH2-02
was created by fusion PCR using the following primers (37): PKH2-02-1,
GGAAGAGGAGTGAGACGTCTGAGAGGGG;PKH2-02-2, ATGGGGA
TATGCATGGCAGTGTGAGAGT; PKH2-02-3, ATGGCCTCCTCGCA
TTTCGGCcaggaaacagctatgaccatg (lowercase bases are complementary to
the nourseothricin marker); PKH2-02-4, catggtcatagctgtttcctgGCCGAA
ATGCGAGGAGGCCAT; PKH2-02-5, cactggccgtcgttttacaacATGGCGG
CAATTCACCGGGTC; PKH2-02-6, GACCCGGTGAATTGCCGCCATg
ttgtaaaacgacggccagtg; PKH2-02-7, TCTCTTCTACCGGCAAGGTCAAA
TTCGG; and PKH2-02-8, CGACTTTTACTCCAAGCTTCCCAAGGGC.
The pkh2-01 and pkh2-02 mutants was obtained from the deletion
collection (31). The deletion of PKH2-02 in the collection strain was con-
firmed using two methods. First, the absence of the PKH2-02 open read-
ing frame (ORF) was confirmed by PCR of genomic DNA isolated from
the reference strains and deletion mutants. Second, quantitative reverse
transcription-PCR (RT-PCR) confirmed that there was no detectable ex-
pression of PKH2-02 in the respective deletion mutants. Primers used in
this experiment were PKH2-02-qPCRF (TCAATGTCTCTTGGTGGACT
GCG) and PKH2-02-qPCRR (TGTCTCTTCTTGGGGGCTGGTAAC).
To ensure that phenotypes were due to PKH2-02 deletion, the mutation
was complemented as follows. PKH2-02 as well as 1,000 bp upstream and
downstream of the ORF was PCR amplified from genomic DNA isolated
from theWT strain from the deletion collection using primers PKH2-02F
(AGGAGTGAGACGTCTGAGAGG) and PKH2-02R (CTGACTGAAAA
ACCCACACC). The product was cloned into pJET-2 (Fermentas, Glen
Burnie, MD) using themanufacturer’s protocol and transformed into the
pkh2-02mutant using a standard biolistic protocol. Candidate transfor-
mants were selected on YPD plates containing 1.5 M NaCl, passaged 3
times on nonselective medium, and selected again on YPD with 1.5 M
NaCl. Integration of the PKH2-02 gene was confirmed by PCR.
Plate-based growth assays. Strains were grown overnight in YPD at
30°C with shaking and diluted to an optical density at 660 nm (OD660) of
1.0 in phosphate-buffered saline (PBS), and a set of 10-fold dilutions was
prepared. The cell suspensions (5l) were spotted onYPDplates contain-
ing calcofluor white (CFW) (1.5 mg/ml), caffeine (10 mM), Congo red (5
mg/ml), and rapamycin (200 ng/ml). For oxidative and nitrosative stress
phenotypes (37), strains (3l each dilution)were plated on yeast nitrogen
base (YNB) (pH 4.0 with succinate) containingH2O2 (1mM), diamide (1
mM), or NaNO2 (1.5 mM). All plates were incubated at 30°C for 3 to 7
days.
C. neoformansmelanin production. Strains were grown overnight in
YPD and diluted to an OD660 of 1.0. Five 10-fold dilutions in PBS were
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spotted (5 l) onto L-3,4-dihydroxyphenylalanine (L-DOPA) plates and
incubated at 30°C for 2 to 10 days.
Antifungal susceptibility assays. Fluconazole and amphotericin B
MICs were determined using Etest strips (AB Biodisk, catalog numbers
510858 and 526348, respectively). Cells were grown overnight in YPD at
30°C with shaking and then diluted to an OD650 of 0.1 in sterile NaCl
solution (0.85%). Sterile cotton swabs were used to streak cells on RPMI
plates (10.4 g/liter RPMI [Sigma, catalog number R6504], 165 mMmor-
pholinepropanesulfonic acid [MOPS], 2% dextrose, and 1.5% Bacto
agar). Immediately after swabbing of cells, Etest strips containing the in-
dicated drug were applied to plates. Plates were incubated at 35°C for 3
days.
Total cellular PKC activity. Total cellular protein kinase C (PKC)
activity was measured using the PepTag assay for nonradioactive detec-
tion of protein kinase C (Promega, Madison, WI) based on procedures
previously reported for C. albicans (38). Briefly, cells were grown over-
night in YPD at 30°C with shaking. Cells were then washed three times
with Dulbecco’s PBS (DPBS) and adjusted to 1 107 cells/ml.Whole-cell
lysates were prepared by glass bead lysis using the extraction buffer pro-
vided in the kit. Equivalent amounts of total cellular proteinwere added to
each reactionmixture. Reaction products were fractionated using agarose
gel electrophoresis, visualized using a GEL DOC system, and quantified
using the histogram function of Adobe Photoshop.
Western blot analysis. Western blot analysis was performed as de-
scribed previously (37). Briefly, cultures were grown overnight in YPD or
YNB at 30°C with shaking and then diluted to an OD660 of 0.2 in 50 ml of
medium. The cells were grown with shaking for 3 h and then treated with
H2O2 (1 mM or 10mM) or NaNO2 (1mM) for 30min or with calcofluor
white (10 g/ml) for 2 h. The cells were diluted 1:1 with ice-cold stop
buffer (0.9% NaCl, 1 mM NaN3, 10 mM EDTA, and 50 mM NaF) and
harvested at 652 g at 4°C for 10 min. Cells were then washed once with
10 ml ice-cold stop buffer. The cell pellet was resuspended in 0.3 ml 1
lysis buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 5 mM EDTA pH
8.2, 5mMEGTA, 0.2mMNa3VO4, 50mMKF, 30mMsodiumpyrophos-
phate, 15 mM p-nitrophenylphosphate, 1 protease inhibitor cocktail
[Roche, catalog number 11836170001], and 10 l/ml each phosphatase
inhibitor cocktail II and III [Sigma, catalog numbers P-5726 and
P-0044]). Cells were then harvested and lysed. Total protein was deter-
mined using theQuick Start Bradford dye reagent (Bio-Rad), and 25 to 50
g of total protein was loaded into precast 4 to 15% gradient or 10%
Mini-Protean TGX (Bio-Rad) gels. Fractionated proteins were trans-
ferred to nitrocellulose membranes and blocked overnight at 4°C (5%
nonfat milk in 50 mMTris [pH 7.5], 150 mMNaCl, and 0.05% Tween 20
[TBST]). The membranes were probed using anti-active MAPK (Pro-
mega, Madison, WI) or phospho-p44/42 MAPK (thr202/Tyr204) rabbit
polyclonal antibody (Cell Signaling Technology) to detect Mpk1 phos-
phorylation followed by anti-rabbit horseradish peroxidase (HRP)-con-
jugated secondary antibody (Bio-Rad). Anti-PSTAIRE or anti-Tsa1 anti-
body was used as a loading control. Blots were visualized with the ECL
Plus Western blotting detection system (GE Healthcare).
Galleria mellonella model of cryptococcosis. C. neoformans cells
were grown overnight in YPD at 30°C. Cells were then washed three times
with Dulbecco’s phosphate-buffered saline (DPBS) and resuspended at a
concentration of 2 107 cells/ml. EachG. mellonella larva was injected in
the terminal pseudopod with 5 l of the inoculum (39). Larvae were
incubated at 30°C, and virulence was measured by scoring the survival of
the larvae every 24 h. The survival of groups of Galleria infected with
different mutants was compared by Kaplan-Meier analysis.
Survival ofC. neoformans cells in J774 cells. J774 cells were seeded at
a concentration of 2 105 cells/ml in a 24-well plate for 18 h. Overnight
yeast cultures were washed three times with DPBS, adjusted to 2  106
cells/ml, and opsonized with monoclonal antibody (MAb) 18B7 (kindly
provided by ArturoCasadevall) for 1 h. Yeast strains were then cocultured
with J774 cells for 80 min. Each well was washed with DPBS to remove
unattached yeasts, and fresh medium was added. Plates were incubated
for an additional 18 h. J774 cells were lysed with cold sterile water and
lysates plated on YPD and incubated at 30°C for 48 h. To control for the
slight growth defect of the pkh2-02 mutant at 37°C, the C. neoformans
strains were incubated in tissue culture medium alone in parallel with the
phagocyte experiments (40). The survival data were then normalized to
growth in the absence of macrophages to give the survival ratio (macro-
phages with yeast/yeast in medium).
ROS production by primed J774 cells.Overnight yeast cultures were
washed three times with Hanks balanced salt solution (HBSS) and ad-
justed to a cell density of 1 108 cells/ml. Yeast were then opsonized
utilizing MAb 18B7 for 1 h and added to J774 cells (multiplicity of infec-
tion [MOI], 5:1) in white, opaque-bottom 96-well microtiter plates
(Corning Incorporated, Corning, NY). Following a previously published
protocol (34), ROS production was measured by luminal-enhanced
chemiluminescence using the Superluminol kit (World Precision Instru-
ments, Inc., Sarasota, FL). Briefly, a mixture containing luminal, signal
enhancer, and eitherHBSS or phorbolmyristate acetate (PMA)was added
to the wells. Luminescence was measured using a 1-s integration time at
intervals of 45 s over a 3-h incubation time at 37°Cusing a SpectraMaxM5
plate reader (Molecular Devices, Sunnyvale, CA).
TNF- secretion by J774murine phagocytes. Supernatants were col-
lected from the macrophage survival assay plates (described above) and
assayed for TNF- production with the Ready-Set-Go mouse tumor ne-
crosis factor alpha kit (eBioscience, SanDiego, CA) according to theman-
ufacturer’s protocol.
Time-kill assays. C. neoformans cells from overnight cultures were
washed twice with DPBS, adjusted to a density of 2 107 CFU/ml in YPD
(50 ml), and treated with either fluconazole (2 g/ml), OSU-03012 (2
g/ml), or a combination of fluconazole and OSU-0312 at the same con-
centrations. Cultures were incubated at 37°C and 10-fold dilutions plated
on YPD at time points 0 h, 3 h, 6 h, 24 h, and 30 h. Plates were incubated
at 30°C for 48 h and scored for CFU/ml.
Nitrite production by J774 cells. J774 cells were seeded at a density of
2 105 cells/ml and stimulated with lipopolysaccharide (LPS) and IFN-
in a 24-well plate for 22 h. Yeast cells were then added to the wells at 2
106 cells/ml. After 2 h, supernatants were collected and processed. Nitrite
accumulation, an indicator of NO production, was measured using the
Griess reagent (Promega catalog number G2930). Briefly, 50-l aliquots
of 24-h culture supernatants were mixed with an equal amount of Griess
reagent and incubated at room temperature for 15min. The absorbance at
540 nm was measured using the SpectraMax M5 plate reader (Molecular
Devices, Sunnyvale, CA).
RESULTS
C. neoformans PDK1 ortholog Pkh2-02 is required for cell wall
integrity. Recently, we reported that chemical inhibitors of hu-
man PDK1 have potent activity toward C. neoformans and appear
to target the PDK1 ortholog Pkh2-02 (17). The function of PDK1
orthologs (S. cerevisiae PKH1/2 [ScPKH1/2] products) in the
model yeast S. cerevisiae has been extensively investigated, but no
focused studies of PDK1 orthologs in human fungal pathogens
had been reported prior to the initiation of our studies. In addi-
tion, the Lodge laboratory identified PKH2-02 in a screen of theC.
neoformansdeletion collection (31) formutants that are hypersen-
sitive to oxidative and nitrosative stress (P. S. Michener, K. J.
Gerik, and J. K. Lodge, unpublished results). Therefore, we dis-
rupted the C. neoformans var. grubii PDK1 ortholog PKH2-02 in
the KN99 background and obtained similar deletion mutants
from the collection generated by Liu et al. (31). PCR of genomic
DNA confirmed the absence of PKH2-02 from both mutants. In
addition, Quantitative RT-PCR confirmed that the PKH2-02
transcript was present in the parental strain but absent from the
deletionmutant (/CT forWTversus pkh2-02mutant, 2
9.7). In
the context of their large-sale screen of deletionmutants, Liu et al.
Chabrier-Roselló et al.
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(31) found that the pkh2-02 mutant showed a growth defect at
37°C, andwe confirmed this finding (Fig. 1A), while the pkh2-01
mutant showed no growth defect at elevated temperature (data
not shown). Lee et al. also observed identical phenotypes for the
CM108-derived pkh2-01 and pkh2-02 mutants (32). In the
KN99 background, the pkh2-02 mutant was also sensitive to
high-temperature growth, but the phenotype did not manifest
until 39°C (data not shown). For consistency, we focused the re-
mainder of our studies on strains derived from CM018. Reinte-
gration of PKH2-02 restored the high-temperature tolerance as
well as all phenotypes discussed below (Fig. 1A).
Temperature-sensitive growth is a nonspecific phenotype that
can result from a variety of cellular defects. In S. cerevisiae, Pkh
kinases are involved in both plasma membrane- and cell wall-
related processes, both of which affect cellular integrity (21–23).
Supporting a role for PKH2-02 in cellular integrity is the fact that
the deletion mutant is exquisitely sensitive to the detergent SDS
(Fig. 1A) and shows increased trypan blue staining (12) in station-
ary phase (Fig. 1B). Mutations that affect cellular integrity by dis-
rupting cell wall stress responses or cell wall biosynthesis are gen-
erally suppressed by the addition of an osmotic support such as
sorbitol to the growth medium (41). As shown in Fig. 1C, the
temperature-sensitive growth of the pkh2-02 mutant was sup-
pressed by the addition of sorbitol to the medium, suggesting that
PKH2-02may be involved in cell wall integrity.
In S. cerevisiae, the Pkhs are known to regulate cell wall integ-
rity by phosphorylation of Pkc1 (21, 28). We therefore examined
the effect of cell wall stressors on the growth of C. neoformans
pkh2-01 and pkh2-02mutants. As shown in Fig. 2A, the pkh2-
02 mutant is hypersensitive to the chitin/glucan interactor
Congo red. In contrast, the pkh2-02mutant showed only a slight
growth defect in the presence of the chitin-binding dye calcofluor
white. Additionally, many yeast cell wall mutants are hypersensi-
tive to caffeine (41), and consistent with that correlation, the
pkh2-02mutant is dramaticallymore susceptible to caffeine than
the wild type (Fig. 2A). Caffeine has recently been proposed to act
as an inhibitor of target of rapamycin (TOR) in yeast (42), and we
therefore tested the tolerance of the pkh2-02mutant to the spe-
cific TOR inhibitor rapamycin. Consistent with our expectations,
the pkh2-02 mutant is hypersensitive to rapamycin (Fig. 2A)
compared to congenic wild-type strains. This is also consistent
with the observations of Lee et al. (32) and with the fact that the
PDK1/Pkh kinases have been linked to the TOR pathway in both
mammalian and S. cerevisiae systems.
One of the well-characterized ScPkh substrates is ScPkc1 (21,
28), a key kinase in the cell wall integrity (CWI) signaling cascade
andother cellular processes. TheCWIpathway is conserved across
many fungi (41) and is also an important regulator of the cell wall
stress response in C. neoformans (12, 37, 44). We therefore hy-
pothesized that Pkc1 activity may be reduced in pkh2-02 mu-
tants compared to in the WT. To test this hypothesis, we com-
pared the ability of total cellular lysates fromWT, pkh2-02, and
pkh2-02::PKH2-02 strains to phosphorylate the commercially
available, conserved PKC substrate Pkc-tide in vitro. As shown in
Fig. 2B, total cellular Pkc1 activity is reduced in the pkh2-02
mutant and is restored by reintroduction of the PKH2-02 allele.
To test further the role of the Pkhs in CWI signaling, we also
examined the effect of the deletionmutations on phosphorylation
ofMpk1, the terminalMAPK of the CWI pathway (12, 37, 41, 44).
In the absence of cell wall stress, Mpk1 phosphorylation is mark-
FIG 1 PKH2-02 affects high-temperature growth and is required for cellular integrity. (A) A 10-fold dilution series of the indicated strains was spotted on YPD
plates or YPD containing SDS (0.6%) and incubated at 30°C or 37°C for 3 days. (B) Cells from an overnight culture were incubated with trypan blue (0.4%) at
a 1:1 dilution for 15min. One hundred cells were counted per field and scored. There was statistical significance between theWT and the pkh2-02mutant (P
0.0005) but not between theWT and the pkh2-02::PKH2 strain (chi-square test, P 0.05). (D) The indicated strains were streaked on plates containing YPD or
YPD supplemented with 1 M sorbitol and incubated at 37°C for 3 days.
C. neoformans PDK1 in Stress Tolerance
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edly reduced in the pkh2-02mutant compared to theWTand the
revertant (Fig. 2C), a finding consistent with the data reported by
Lee et al. (32). The addition of CFW to the cultures increased
Mpk1 phosphorylation in both the WT and the pkh2-02::
PKH2-02 revertant mutant (37, 44), but only a barely detectable
amount of phosphorylated Mpk1 was observed in the pkh2-02
mutant (Fig. 2C). Thus, it appears that PKH2-02 is required for
full activation of Mpk1 and, in turn, cell wall integrity.
Pkh2-02 is required for tolerance tomembrane-targeted an-
tifungal drugs. Recent work in S. cerevisiae has highlighted the
role of the ScPkh kinases in a wide variety of plasma membrane-
related biological processes (22–24, 26, 27, 45). Consistent with
these findings, Lee et al. demonstrated that pkh2-02 mutants
have an altered sphingolipid content compared to the WT and
show decreased Mpk1 phosphorylation in response to flucona-
zole, a membrane-targeted antifungal drug (32). Since the plasma
membrane and the cell wall are the twomost important targets for
antifungal drugs currently in clinical use, we hypothesized that
PKH2-02 may affect the ability of C. neoformans to tolerate anti-
fungal drug exposure. The twomost important drugs in the treat-
ment of cryptococcosis are amphotericin B and fluconazole (1, 6).
We therefore determined the susceptibility of WT and pkh2-02
cells to these two drugs using the Etest method. As shown in
Fig. 3A, the pkh2-02 mutant is 2- to 3-fold more sensitive
(MIC  0.9) to fluconazole than the WT (MIC  16). This is
consistent with the spot dilution assay-based analysis of pkh2-02
fluconazole sensitivity recently reported by Lee et al. (32).We also
found that pkh2-02 cells are more susceptible to amphotericin B
(Fig. 3B), the gold standard therapy for CEM. In contrast, we
found no difference in the susceptibilities of WT and pkh2-02
cells to caspofungin (data not shown), an echinocandin class an-
tifungal to which C. neoformans is quite resistant (8).
Asmentioned above, one of our laboratories has recently dem-
onstrated that molecules which inhibit hPDK1 also have antifun-
gal activity and appear to target fungal Pkh kinases as part of their
mechanism of action (17). Based on the results from Fig. 3A, we
hypothesized that hPDK1 inhibitors could be synergistic with flu-
conazole. To test this hypothesis, we performed time-kill assays
with fluconazole and the hPDK1 inhibitor OSU-03012 (Fig. 3C).
The combination of fungistatic concentrations ofOSU-03012 and
fluconazole resulted in a3-log10 decrease in the starting inocu-
FIG 2 PKH2-02 is involved in cell wall integrity and activation of the cell wall integrity MAPK pathway. (A) A 10-fold dilution series of the indicated strains was
spotted on YPD plates containing Congo red (5 mg/ml), calcofluor white (1.5 mg/ml), caffeine (10 mM), and rapamycin (200 ng/ml). (B) The indicated strains
were processed for total cellular Pkc1 activity using the Promega PepTag kit as described in Materials andMethods. (C) Cell lysates from log-phase cells treated
with either solvent (water) or CFW (10 g/ml) were analyzed by Western blotting with phospho-specific antibodies for Mpk1 phosphorylation; anti-PSTAIRE
is a loading control.
FIG 3 Pkh2-02 is required for tolerance of membrane-targeted antifungal
drugs. (A and B) Etest strips containing fluconazole or amphotericin B were
applied to YPD plates swabbed with WT, pkh2-02, and pkh2::PKH2-02
strains. Plates were incubated at 35°C for 3 days. Bars represent the meanMIC
from at least two independent experiments performed in triplicate. Error bars
indicate standard deviations. (C) Cultures containing 2 107 CFU/ml of WT
cells in YPDwere treatedwith fluconazole (Flu) (2g/ml), OSU-03012 (OSU)
(2g/ml), or a combination of both drugs at the same concentration. Cultures
were incubated at 37°C and plated, and the number of colony-forming units
(CFU)/ml was determined at the indicated time points.
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lum of C. neoformans serotype A, indicating that the addition of
OSU-03012 to fluconazole results in a fungicidal combination.
These data strongly suggest that Pkh activity is required for toler-
ance of plasma membrane-targeted antifungal drugs.
Pkh2-02 is required for nitrosative and oxidative stress tol-
erance.Akey characteristic ofC. neoformans is its ability to survive
and replicate within the phagolysosomes of macrophages (46).
This ability is, in turn, dependent on the organism’s tolerance of
oxidative and nitrosative stresses (47). Since Pkc1 activity is re-
quired for oxidative and nitrosative stress tolerance in C. neofor-
mans (37) and is reduced in pkh2-02 mutants (Fig. 2B), we hy-
pothesized that Pkh2-02 may be required for growth in the
presence of oxidative and/or nitrosative stress. As shown in
Fig. 4A, the pkh2-02 mutant is exquisitely sensitive to H2O2,
NaNO2, and diamide compared to theWT. To further explore the
role of Pkh2-02 in oxidative and nitrosative stress tolerance, we
examined the effects of NaNO2 and H2O2 treatment on the phos-
phorylation ofMpk1. As shown in Fig. 4B andC,Mpk1phosphor-
ylation is decreased in the pkh2-02 mutant relative to both the
WT and the pkh2-02::PKH2-02 complement. These observa-
tions strongly suggest that Pkh2-02 is required for the activation of
the CWI pathway in response to nitrosative and oxidative stress.
Pkh2-02 is required for temperature-independent virulence
in a Galleria model of cryptococcosis. As reported by Liu et al.
(31), the pkh2-02 mutant showed infectivity defects in a large-
scale competitive fitness assay using a murine model of pulmo-
nary cryptococcosis. Since this strain also showed a growth defect
at 37°C, the infectivity defect of the pkh2-02mutant was reason-
ably attributed to this well-known Cryptococcus virulence trait.
Similar findings were also reported by Lee et al. using a tail vein
inoculation model of disseminated cryptococcosis (32). Because
our studies as well as those reported by Lee et al. (32) and Liu et al.
(31) indicated that loss of PKH2-02 affects a number of important
cellular processes that could also influence pathogenesis, we hy-
pothesized that pkh2-02mutantsmight display virulence defects
independent of high-temperature growth. To test this hypothesis,
we took advantage of the ability of C. neoformans to cause disease
in Galleria mellonella at temperatures below mammalian body
temperature (37°C) as a means to further dissect the role of
PKH2-02 in C. neoformans pathogenesis (48). As shown in Fig. 5,
infection ofG.mellonella caterpillars with 1 105 CFU/larva leads
more than	40%mortality by 11 days postinfection, whereas the
pkh2-02mutant is avirulent (P 0.04 by theKaplan-Meier test).
The complemented mutant (Fig. 5) was not statistically different
from the WT (P 0.05).
To explore the mechanistic basis for the high-temperature
growth-independent role of PKH2-02 in pathogenesis, we exam-
ined the ability of the pkh2-02mutant to form capsule and mel-
anin, two other important C. neoformans virulence factors (49).
Consistent with the findings of Liu et al. (31), we found no differ-
ence in capsule formation between the pkh2-02mutant and the
WTusing a variety of assays, including India ink staining, anticap-
sular antibody binding, and plate-based assays (data not shown).
In the CM018 background, the pkh2-02 mutant showed a very
mild defect inmelanin formation onmediumcontaining L-DOPA
(Fig. 6A). However, this defect is not present in the KN99 back-
ground. As is evident from the plates shown in Fig. 6A, the CM018
reference strain does notmelanize as strongly asKN99under our
assay conditions. We have tested the phenotype multiple times,
and it is complemented by reintroduction of PKH2-02 (Fig. 6A).
Neither Liu et al. (31) nor Lee et al. (32) reported a defect in
melanization for the pkh2-02 mutant. However, the defect is
quite minor and may not have been evident under the conditions
used in the other laboratories. We interpret these results to indi-
cate that Pkh2-02 has, at most, a minor role in melanin formation
FIG 4 PKH2-02 is required for oxidative and nitrosative stress tolerance. (A) A 10-fold dilution series of the indicated strains was spotted on YNB (pH 4.0)
supplementedwithH2O2 (1.5mM),NaNO2 (1.5mM), or diamide (1mM). (B andC)Cell lysates from log-phase cells exposed to eitherNaNO2 (1mM) orH2O2
(1 mM or 10 mM) were analyzed for Mpk1 phosphorylation utilizing phospho-p44/42 MAPK. Anti-PSTAIRE and anti-Tsa1 are loading controls.
FIG 5 PKH2-02 is required for virulence in the G. mellonella model. G. mel-
lonella larvae were injected in the terminal pseudopod with WT, pkh2-02,
and pkh2-02::PKH2-02 strains at a concentration of 2 105 CFU/larva and
incubated at 30°C. Survival was scored every 24 h. The survival difference
between theWT and pkh2-02 strains was statistically significant (P
 0.05 by
the Kaplan-Meier test).
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because its effect is apparent only when the strain background
itself is relatively inefficient at melanization. As such, it seems
likely that there are uncharacterized mutations in the CM018
background that are required to reveal the minor role of Pkh2-02
in melanization.
The pathogenesis of C. neoformans is intimately related to the
ability of the organism to survive and replicatewithin the phagoly-
sosome (46, 50). Thus, the hypersensitivity of the pkh2-02 mu-
tant to oxidative and nitrosative stress suggested that its temper-
ature-independent pathogenesis defect may be related to
decreased replication or survival in the phagolysosome (47). To
test this possibility, we compared the ability of the pkh2-02mu-
tant to survive in the murine macrophage-like cell line J774, a
well-studiedmodel for the interaction ofC. neoformanswithmac-
rophages. C. neoformans cells were opsonized with anticapsular
antibody prior to addition to otherwise unactivated J774 cells
(51). To control for the decreased growth rate of the pkh2-02
mutant at 37°C, identical wells lacking J774 cells were processed in
parallel, and growth of the C. neoformans cells in J774 cells was
normalized to growth in medium alone (47). Under these condi-
tions, WT cells replicate within J774 cells more efficiently than in
medium alone while pkh2-02 cells show a statistically significant
decrease (2-fold decrease;P
 0.05 by Student’s t test) in growth in
the presence of J774 cells (Fig. 6B). It is important to note that we
could detect no difference in the ability of J774 cells to phagocy-
toseWT and pkh2-02 cells (data not shown). These data strongly
suggest that PKH2-02 is involved in regulating processes required
forC. neoformans to survivewithin phagocytes and that the inabil-
ity to replicate within macrophages contributes to the tempera-
ture-independent virulence defects displayed by the pkh2-02
mutant. The in vitro hypersensitivity to oxidative and nitrosative
stress displayed by the pkh2-02 mutant coupled with the de-
creased activation of the CWI pathway in response to these
stresses likely contributes to the observed defects in macrophage
survival.
Phagocytes exposed to the pkh2-02 mutant produce in-
creased levels of TNF- and reactive oxygen species compared
to those exposed to the wild type. Our results indicate that
Pkh2-02 regulates processes that are important for both cell wall
and plasma membrane homeostasis. Since cell surface structures
such as these represent the point of contact between the host and
pathogen, we hypothesized that interactions between Cryptococ-
cus and the phagocytemay also be altered in pkh2-02mutants. In
addition to tolerance of the oxidative and nitrosative stresses pres-
ent in the phagolysosome, Cryptococcus cells are able to modulate
the activation of phagocytes as part of an immune evasion strategy
(46). For example, primed phagocytes challenged with Cryptococ-
cus secrete lower levels of TNF- than unchallenged primed
phagocytes (52). To test the effect of deletion of PKH2-02 on this
immune evasion property of Cryptococcus, we compared the
amounts of TNF- secreted by J774 cells that had been cocultured
with either the WT or the pkh2-02 mutant. As previously re-
ported (52), addition of WT cells to primed J774 phagocytes sig-
nificantly reduced the amount of TNF- secreted into the me-
dium (Fig. 7A). This suppression was abolished in the pkh2-02
mutant, and the amount of TNF- secreted into the medium of a
coculture of the pkh2-02mutantwas indistinguishable from that
for unchallenged J774 cells (Fig. 7A). Reintroduction of the
PKH2-02 allele restored the ability of the mutant to suppress
TNF- production by J774 cells. Thus, PKH2-02 appears to im-
pact processes that are required forC. neoformans tomodulate the
innate immune response.
It has also been shown previously that primed murine phago-
cytes do not induce nitric oxide synthase in response to C. neofor-
mans (53).We therefore asked if deletion of PKH2-02 affected the
amount of nitrite produced by murine phagocytes. As shown in
Fig. 7B, nitrite concentrations in the coculture supernatants of
J774 cells with WT and pkh2-02 mutant cells were essentially
identical. A second important component of the phagocyte re-
sponse tomicrobial pathogens is the generation of reactive oxygen
species (ROS). Interestingly, the production ofROSbyphagocytes
challenged with Cryptococcus has not previously been reported to
our knowledge. We therefore compared the amount of ROS gen-
erated by primed J774 cells in the presence and absence ofWT and
pkh2-02mutant cells. OpsonizedC. neoformans cells were added
to J774 cells primedwith PMA to activate ROS production using a
modification of a procedure previously developed to assay the
interaction of Candida albicans with J774 cells (33–35). The addi-
tion of WT C. neoformans significantly decreased the amount of
ROS production induced by PMA relative to that for activated
J774 cells that were not exposed to C. neoformans (Fig. 7C). In
contrast, the pkh2-02 mutant induced significantly more ROS
production by J774 cells than the WT (P 
 0.01), while cells of
the complemented mutant were not significantly different from
theWT. These data indicate thatC. neoformans alsomodulates the
ability of phagocytes to generate ROS and that Pkh2-02-regulated
processes are required for this modulation to occur normally.
Since the modulation of ROS production in primed J774 cells
FIG 6 Deletion of PKH2-02 affects melanization and survival in phagocytes. (A) Ten-fold dilutions of the indicated strains were spotted onto L-DOPA plates,
incubated at 30°C for 5 days, and photographed. (B)Macrophage survival studies were performed utilizing J774 cells as detailed inMaterials andMethods. Data
were normalized to growth in the absence of macrophages to obtain the survival ratio. The bars indicate means from two independent experiments performed
in triplicate, and error bars indicated standard deviations. Differences between strains were analyzed by Student’s t test, and the P value is indicated over the
bracket.
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byC. neoformans has not been studied previously, we examined its
dependence on the production of capsule and melanin using the
acapsular cap59 mutant and the melanin-deficient lac1 mu-
tant. As shown in Fig. 7D, neither mutant was significantly differ-
ent from theWTwith respect to ROS production. Similarly, a lack
of CWI pathway signaling in the pkh2-02 strains does not ex-
plain its increased ROS production, because thempk1mutant is
indistinguishable from theWT. Further studies will be required to
identify the mechanistic basis of the ability of C. neoformans to
suppress ROS production in phagocytes. Taken together, our re-
sults suggest that a combination of decreased tolerance to the ox-
idative/nitrosative environment of the phagolysosome and in-
creased production of ROS may contribute to the temperature-
independent virulence defects displayed by the pkh2-02mutant.
DISCUSSION
Protein kinase-based signaling pathways are crucial mediators of
processes through which fungi adapt to environmental stresses,
survive within the host, cause disease, and tolerate antifungal
drugs (9–11). Recently, we identified fungal orthologs of human
PDK1 kinases as an attractive target for antifungal drug develop-
ment (17). In order to better understand the function of these
kinases in pathogenic fungi, we have carried out a genetics-based
study to characterize C. neoformans mutants lacking the hPDK1
ortholog Pkh2-02. As discussed above, while our work was in its
final stages, Lee et al. reported that PKH2-02 plays a role in flu-
conazole tolerance and affects sphingolipid metabolism (32). Be-
tween our work and that of Lee et al. and Liu et al. (31), PKH2-02
has been deleted in three different genetic backgrounds of sero-
type AC. neoformans var. grubii. Overall, the phenotypes that have
been examined in all three backgrounds have been highly concor-
dant. However, there appears to be some variation in the pen-
etrance of high-temperature tolerance and melanization depend-
ing on the specific genetic background. There do not appear to be
overlapping ORFs in the chromosomal region of PKH2-02 that
could have been differentially disrupted by the deletion strategies
used to generate the mutants. Another explanation for the back-
ground variations observed for the PKH2-02 mutants is that
PKH2-01may be differentially regulated in the backgrounds and,
thus, more or less able to compensate for loss of PKH2-02. How-
ever, as Lee et al. reported (32), PKH2-01 lacks the canonical se-
quences of a PDK1 and thus may not be biochemically related.
Furthermore, we measured the expression of PKH2-01 in wild-
type and pkh2-02 mutant strains from the CM108 and KN99
backgrounds and could find no differences (data not shown). Be-
cause the Pkh kinases appear to function in awide range of cellular
processes, we suspect that the slight variation in phenotypes may
be related to uncharacterized background mutations.
ScPkhs are known to be involved in cell wall integrity signaling
(7, 21), and therefore, we were interested in determining whether
Pkhs also play a role in cell wall integrity. The pkh2-02 mutant
displays two phenotypes that suggest a role for the Pkhs in cell wall
integrity. First, the growth defect displayed by the pkh2-02mu-
FIG 7 Primed phagocytes challenged with the pkh2-02mutant produce increased levels of TNF- and ROS relative to those challenged with the wild type. (A)
The indicated strains were opsonized with MAb 18B7 for 1 h and cocultured with J774 cells that had been prestimulated with LPS and IFN- for 24 h.
Supernatants were collected and analyzed for the presence of TNF- as described inMaterials andMethods. (B) Opsonized C. neoformans cells were cocultured
with LPS- and IFN--prestimulated J774 cells for 2 h. The nitrite concentration in the supernatants was determined using the Griess reagent kit. (C and D) The
indicated strains were opsonized and cocultured with PMA-stimulated J774 cells. ROS were measured by luminal-enhanced chemiluminescence as described in
Materials andMethods. For all panels, the solid bars indicatemean values and error bars indicate the standard deviation for at least two independent experiments
performed in triplicate. Differences between strains were analyzed by Student’s t test with statistical significance set at P
 0.05. NS, not significant.
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tant at elevated temperature is suppressed by the addition of sor-
bitol to the growth medium (Fig. 1D). Osmoremedial tempera-
ture sensitivity is a classic phenotype for mutants with cell wall
defects in all fungal species. Second, pkh2-02 cells are hypersen-
sitive to the effects of Congo red, a dye that appears to interfere
with cell wall chitin and glucan architecture (Fig. 2A). Interest-
ingly, the pkh2-02mutant shows only modest growth defects in
the presence of calcofluor white (Fig. 2A), a dye that interferes
with chitin and is typically more toxic to cell wall mutants (41).
However, previous work in the Lodge laboratory has shown that
deletion of components of the CWI MAPK signaling pathway in
C. neoformans leads to hypersensitivity to Congo red but not to
calcofluor white (12). Similarly, CWI pathway mutants also dis-
play osmoremedial temperature sensitivity. Thus, with respect to
cell wall defects, pkh2-02mutants share similar phenotypes with
CWI pathway mutants, consistent with previous results in S.
cerevisiae indicating that fungal PDK1 orthologs function in the
CWI pathway (19, 21, 28).
TheCWIMAPK signaling pathway is highly conserved in fungi
(45). At the top of this cascade is Pkc1, an ACG kinase that is a
substrate of ScPkhs; the terminal MAPK is presumed to be Mpk1
(21, 41, 44). As shown in Fig. 2B and C, cellular Pkc1 activity and
Mpk1 phosphorylation are decreased in pkh2-02 mutants, fur-
ther supporting a role for PKH2-02 in the regulation of the CWI
pathway and the notion that, as in S. cerevisiae, Pkc1 is a substrate
of Pkh2-02. Indeed, Pkc1 contains a sequence that matches the
consensus PDK1/Pkh phosphorylation motif (TFCGTPEF) iden-
tified in human and S. cerevisiae substrates (18). Lee et al. found
that Pkh2-02 is involved in fluconazole-triggered phosphoryla-
tion of Mpk1 as well (32). However, it is important to note that
both our results and those of Lee et al. indicate that low levels of
Mpk1 phosphorylation occur in the absence of PKH2-02 (Fig.
2C). Thus, PKH2-02 is required for full activation of the CWI
pathway but is not absolutely required for its activity. This is also
consistent with the fact that cells lacking Pkh2-02 are viable. De-
letion of PKC1 in C. neoformans (37) results in more severe phe-
notypes than those observed in cells lacking Pkh2-02. Therefore, if
Pkh2-02 phosphorylationwere absolutely required for Pkc1 activ-
ity, then deletion of PKH2-02 should yield a more severe pheno-
type than that observed.
The TOR pathway is also an important signaling network with
which ScPkh1/2 kinases interact. Both we and Lee et al. (32) have
found that the pkh2-02 mutant is hypersensitive to rapamycin,
indicating that this interaction is operative in C. neoformans as
well.We also found that caffeine, which appears to inhibit TOR as
part of its mechanism of action, is more toxic to pkh2-02 cells
than to WT cells. In S. cerevisiae, mutants with mutations of the
ScPKH1/2 substrate ScYPK1 are hypersensitive to rapamycin (53),
and similarly, Lee et al. also showed that deletion of YPK1, a likely
substrate of PKH2-02, increases sensitivity to rapamycin (32).
Furthermore, this group also showed that a threonine-to-alanine
mutation in the putative Pkh2-02 phosphorylation site of YPK1
also caused rapamycin sensitivity (32). Taken together, these ob-
servations are consistent with the idea that the hypersensitivity of
the pkh2-02mutant to rapamycin is due to decreased activation
of Ypk1.
In addition to regulating cell wall integrity, Pkc1 plays an im-
portant role the ability of C. neoformans to withstand oxidative
and nitrosative stress (37). Since C. neoformans replicates within
the phagolysosomes of macrophages, oxidative and nitrosative
stress tolerance is an important feature of its physiology and
pathogenesis (47). Deletion of PKC1 results in oxidative and ni-
trosative stress sensitivity, and the CWI pathway is activated by
H2O2 and NO as evidenced by phosphorylation of Mpk1. How-
ever, the downstream components of the CWI pathway are dis-
pensable for resistance to these stresses (37). Similar to the pkc1
mutant, the pkh2-02 mutant is sensitive to both H2O2 and NO
and fails to activate the CWI pathway in response to oxidative and
nitrosative stress. These data are paralleled by results that show
that Pkh2-02 is necessary for the suppression of ROS production
in themacrophage-like cell line in anMpk1-independentmanner.
Taken together, these data suggest that responses to oxidative
stress, including resistance to and suppression of the oxidative
burst, are mediated by Pkc1 but not the remainder of the CWI
pathway. Although a pkc1mutant is available (37), it requires an
osmotic support for viability and therefore could not be directly
tested in parallel experiments. Taken together, these results sug-
gest that PKH2-02 may play an important role in macrophage
survival and, hence, pathogenesis.
Previous studies by both Liu et al. (31) and Lee et al. (32)
indicated that pkh2-02 mutants have decreased virulence in
mouse models of cryptococcosis. However, as both groups noted,
this effect ismost likely due to the high-temperature growth defect
displayed by pkh2-02 cells. Using the Galleria mellonella model
at low temperature (48), we found that themutant is also avirulent
at reduced temperature, indicating that Pkh2-02 regulates pro-
cesses important for virulence independent of high-temperature
growth. Furthermore, our data indicate that the pkh2-02mutant
is unable to replicate within phagocytes after controlling for
slower growth of the mutant at 37°C.
A reasonable explanation for these results is that the pkh2-02
mutant is unable to tolerate the oxidative environment of the
phagocyte. It is likely that multiple defect in pkh2-02 cells con-
tribute to this inability to survive in the phagolysosome. First, Lee
et al. have shown that lipid metabolism (32) and, consequently,
the plasmamembrane are altered. Defects in membrane structure
and function are likely to decrease cellular integrity in the face of
oxidative stress. Second, we have shown that activation of CWI
pathway-mediated stress responses to nitrosative and oxidative
stress is blunted in the pkh2-02mutant, indicating that compen-
satory adaptations to oxidative stress are defective in the mutants.
In principle, two other characteristics of C. neoformans that con-
tribute to its virulence and survival in macrophages are capsule
andmelanin production.Wewere unable to detect any alterations
in capsule formation between the pkh2-02 mutant and WT
strains, which is similar to the findings of Lee et al. (32) and Liu et
al. (31).
On L-DOPA-containing medium, the pkh2-02mutant in the
CM018 background used in the deletion collection shows a very
minor defect in melanization, whereas the KN99-derived pkh2-
02 mutant showed melanization similar to that of the WT. We
carried out our virulence and phagocyte interaction studies in the
CM018 background, and it is possible that reduced melanization
contributes to the decreased survival of the pkh2-02 mutant in
phagocytes and decreased virulence. Since themelanization defect
is quiteminor, however, it is unlikely to be the sole explanation for
the sensitivity to oxidative stress and phagocytes displayed by the
pkh2-02mutant. Taking these findings together, it appears that
Pkh2-02 regulates a variety of cellular processes that both directly
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and indirectly affect the ability of C. neoformans to adapt to the
harsh environment of the phagolysosome.
C. neoformans also employs a number of immune evasion
strategies to survive and replicate within phagocytes (46, 49, 52,
54). One of these mechanisms is based the ability to suppress
TNF- secretion by phagocytes (52). Similarly, C. neoformans
suppresses the ability of phagocytes to produce antimicrobial ni-
tric oxide species (54) and, as we have shown here, ROS. We have
found that Pkh2-02 is required for the ability of C. neoformans to
suppress TNF- secretion and ROS production but not nitrite
formation (52, 54). Previous studies have shown that C. neofor-
mans capsular polysaccharide glucuronoxylomannan (GXM)
contributes significantly to the ability ofC. neoformans to suppress
TNF- and nitrite production. For example, primed phagocytes
challenged with acapsular mutants of C. neoformans produce in-
creased levels of both TNF- and nitrite compared to WT cells.
However, it is important to note that acapsular mutants still in-
duce less TNF- and nitrite production than the WT (52, 54),
suggesting that capsule-independent mechanisms may play a role
in this immune evasion strategy. Since neither we nor others have
found that pkh2-02 mutants display readily detectable altera-
tions in the amount of capsule produced, it is possible that
Pkh2-02 function is required for capsule-independent mecha-
nisms by whichC. neoformansmodulates TNF- production. It is
also possible that loss of Pkh2-02 function leads to more subtle
changes in capsule structure that are required for GXM to interact
with the phagocyte and carry out its immunomodulatory func-
tions.
One of the hallmark functions of phagocytes is the generation
of ROS in response tomicrobes. To our knowledge, the effect ofC.
neoformans on this important function of phagocytes had not
been previously studied. Similar to its effect on TNF- and nitrite
production (52, 54), here we have shown that C. neoformans sup-
presses the production of ROS by stimulated murine phagocytes
in a capsule- and melanin-independent fashion. Additional work
will be required to fully define the mechanisms of this immuno-
modulatory strategy of C. neoformans. The ability of other patho-
genic fungi such as C. albicans and Histoplasma capsulatum to
detoxify ROS through cell surface-localized superoxide dismuta-
ses has been reported recently (33–35). Because Pkh2-02 affects
cell surface-associated processes, it is possible that loss of Pkh2-02
activity disrupts the localization, secretion, or activity of Sod1, the
cell surface-localized superoxide dismutase in C. neoformans (43,
55). Experiments directed toward testing these hypotheses are in
progress and will be reported in due course.
In summary, our results as well as those recently reported by
others indicate that the C. neoformans PDK1 ortholog Pkh2-02 is
a key signaling kinase that affects a wide range of physiologic
and pathogenic processes in this important human pathogen.
Certainly, more work will be required to dissect the cellular and
molecular mechanisms by which this kinase carries out its
functions. Accordingly, it seems likely that such experiments
will provide important insights into the biology and pathogen-
esis of C. neoformans.
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